KesslerCS, KaneK, DevS, . Inadequate postgraduate training of skin and soft tissue infections in an era of community-associated methicillin-resistant Staphylococcus aureus. J Investig Med. 2013; 61(6): 1026–1029.
2.
MoranGJ, KrishnadasanA, GorwitzRJ, . Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006; 355: 666–674.
PallinDJ, BinderWD, AllenMB, . Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis. 2013; 56: 1754–1762.
5.
RayGT, SuayaJA, BaxterR. Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large US. integrated health care organization.J Clin Microbiol. 2012; 50: 1950–1957.
6.
SchmitzGR, BrunerD, PitottiR, . Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 2010; 56: 283–287.
7.
DuongM, MarkwellS, PeterJ, . Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010; 55: 401–407.
8.
LiuC, BayerA, CosgroveSE, . Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52: e18–e55.
9.
PallinDJ, EganDJ, PelletierAJ, . Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008; 51: 291–298.
